Hoxa6 potentiates short-term hemopoietic cell proliferation and extended self-renewal

Experimental Hematology

Volumn 37, Issue 3, 2009, Pages

  Dickson, Glenda J ^a   Kwasniewska, Alexandra ^a   Mills, Ken I ^a   Lappin, Terence R J ^a   Thompson, Alexander ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; GENE PRODUCT; GROWTH FACTOR; PROTEIN HOXA6; PROTEIN HOXA9; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; GENE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HOMEOBOX; HOXA6 GENE; HOXA9 GENE; LEUKEMOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

MURINAE;

EID: 59749104864     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.10.015     Document Type: Article

References (62)

1. Duboule D. The rise and fall of Hox gene clusters. Development 134 (2007) 2549-2560
2. Lewis E.B. A gene complex controlling segmentation in Drosophila. Nature 276 (1978) 565-570
3. Kmita M., and Duboule D. Organizing axes in time and space; 25 years of colinear tinkering. Science 301 (2003) 331-333
4. Argiropoulos B., and Humphries R.K. Hox genes in hematopoiesis and leukemogenesis. Oncogene 26 (2007) 6766-6776
5. Grier D.G., Thompson A., Kwasniewska A., McGonigle G.J., Halliday H.L., and Lappin T.R. The pathophysiology of HOX genes and their role in cancer. J Pathol 205 (2005) 154-171
6. Buske C., and Humphries R.K. Homeobox genes in leukemogenesis. Int J Hematol 71 (2000) 301-308
7. Somervaille T.C., and Cleary M.L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10 (2006) 257-268
8. Kawagoe H., Humphries R.K., Blair A., Sutherland H.J., and Hogge D.E. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia 13 (1999) 687-698
9. Thorsteinsdottir U., Mamo A., Kroon E., et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99 (2002) 121-129
10. Sauvageau G., Thorsteinsdottir U., Eaves C.J., et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev 9 (1995) 1753-1765
11. Beslu N., Krosl J., Laurin M., Mayotte N., Humphries K.R., and Sauvageau G. Molecular interactions involved in HOXB4-induced activation of HSC self-renewal. Blood 104 (2004) 2307-2314
12. Schiedlmeier B., Santos A.C., Ribeiro A., et al. HOXB4's road map to stem cell expansion. Proc Natl Acad Sci U S A 104 (2007) 16952-16957
13. Lawrence H.J., Helgason C.D., Sauvageau G., et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89 (1997) 1922-1930
14. Lawrence H.J., Christensen J., Fong S., et al. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 106 (2005) 3988-3994
15. Bijl J., Thompson A., Ramirez-Solis R., et al. Analysis of HSC activity and compensatory Hox gene expression profile in Hoxb cluster mutant fetal liver cells. Blood 108 (2006) 116-122
16. Palmqvist L., Pineault N., Wasslavik C., and Humphries R.K. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes. PLoS ONE 2 (2007) e768
17. Drabkin H.A., Parsy C., Ferguson K., et al. Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia. Leukemia 16 (2002) 186-195
18. Bullinger L., Dohner K., Bair E., et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 350 (2004) 1605-1616
19. Heuser M., Beutel G., Krauter J., et al. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 108 (2006) 3898-3905
20. Cauwelier B., Cave H., Gervais C., et al. Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia 21 (2007) 121-128
21. Kumar A.R., Hudson W.A., Chen W., Nishiuchi R., Yao Q., and Kersey J.H. Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia. Blood 103 (2004) 1823-1828
22. Bijl J., Sauvageau M., Thompson A., and Sauvageau G. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia. Genes Dev 19 (2005) 224-233
23. Mamo A., Krosl J., Kroon E., et al. Molecular dissection of Meis1 reveals 2 domains required for leukemia induction and a key role for Hoxa gene activation. Blood 108 (2006) 622-629
24. Dorrance A.M., Liu S., Yuan W., et al. Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. J Clin Invest 116 (2006) 2707-2716
25. Bansal D., Scholl C., Frohling S., et al. Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model. Proc Natl Acad Sci U S A 103 (2006) 16924-16929
26. Horton S.J., Grier D.G., McGonigle G.J., et al. Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells. Cancer Res 65 (2005) 9245-9252
27. Spooncer E., Boettiger D., and Dexter T.M. Continuous in vitro generation of multipotential stem cell clones from src-infected cultures. Nature 310 (1984) 228-230
28. Zhu J., Heyworth C.M., Glasow A., et al. Lineage restriction of the RARalpha gene expression in myeloid differentiation. Blood 98 (2001) 2563-2567
29. Tsai S., Bartelmez S., Sitnicka E., and Collins S. Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes Dev 8 (1994) 2831-2841
30. Dagher R.N., Hiatt K., Traycoff C., Srour E.F., and Yoder M.C. c-Kit and CD38 are expressed by long-term reconstituting hematopoietic cells present in the murine yolk sac. Biol Blood Marrow Transplant 4 (1998) 69-74
31. Thompson A., Quinn M.F., Grimwade D., et al. Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Blood 101 (2003) 1558-1565
32. Dickson G.J., Lappin T.R.J., and Thompson A. Complete array of HOX gene expression by RQ-PCR. In: So C.W. (Ed). Methods in Molecular Medicine: Acute Leukemia. 1st ed (2008), Humana Press, NJ In press
33. Morrow M., Horton S., Kioussis D., Brady H.J., and Williams O. TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activity. Blood 103 (2004) 3890-3896
34. Heyworth C.M., Dexter T.M., Kan O., and Whetton A.D. The role of hemopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotential stem cells. Growth Factors 2 (1990) 197-211
35. Bruno L., Hoffmann R., McBlane F., et al. Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Mol Cell Biol 24 (2004) 741-756
36. Omidvar N., Pearn L., Burnett A.K., and Darley R.L. Ral is both necessary and sufficient for the inhibition of myeloid differentiation mediated by Ras. Mol Cell Biol 26 (2006) 3966-3975
37. Magli M.C., Barba P., Celetti A., De Vita G., Cillo C., and Boncinelli E. Coordinate regulation of HOX genes in human hematopoietic cells. Proc Natl Acad Sci U S A 88 (1991) 6348-6352
38. Pineault N., Helgason C.D., Lawrence H.J., and Humphries R.K. Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny. Exp Hematol 30 (2002) 49-57
39. Wong P., Iwasaki M., Somervaille T.C., So C.W., and Cleary M.L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev 21 (2007) 2762-2774
40. Wang W., Horner D.N., Chen W.L., Zandstra P.W., and Audet J. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects. Biotechnol Bioeng 99 (2008) 1261-1272
41. Lessard J., and Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423 (2003) 255-260
42. Park I.K., Qian D., Kiel M., et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
43. Taghon T., Thys K., De Smedt M., et al. Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development. Leukemia 17 (2003) 1157-1163
44. Abramovich C., and Humphries R.K. Hox regulation of normal and leukemic hematopoietic stem cells. Curr Opin Hematol 12 (2005) 210-216
45. Dupe V., Davenne M., Brocard J., et al. In vivo functional analysis of the Hoxa-1 3′ retinoic acid response element (3′RARE). Development 124 (1997) 399-410
46. Oosterveen T., Niederreither K., Dolle P., Chambon P., Meijlink F., and Deschamps J. Retinoids regulate the anterior expression boundaries of 5' Hoxb genes in posterior hindbrain. EMBO J 22 (2003) 262-269
47. Ma X., Husain T., Peng H., et al. Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA library. Blood 100 (2002) 833-844
48. Fuller J.F., McAdara J., Yaron Y., Sakaguchi M., Fraser J.K., and Gasson J.C. Characterization of HOX gene expression during myelopoiesis: role of HOX A5 in lineage commitment and maturation. Blood 93 (1999) 3391-3400
49. Lawrence H.J., Rozenfeld S., Cruz C., et al. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13 (1999) 1993-1999
50. Magnusson M., Brun A.C., Miyake N., et al. HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood 109 (2007) 3687-3696
51. Cheng F., Liu J., Zhou S.H., Wang X.N., Chew J.F., and Deng L.W. RNA interference against mixed lineage leukemia 5 resulted in cell cycle arrest. Int J Biochem Cell Biol 40 (2008) 2472-2481 Epub 2008 May 15
52. Grubach L., Juhl-Christensen C., Rethmeier A., et al. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. Eur J Haematol 81 (2008) 112-122 Epub 2008 Jun 28
53. Liu H., Takeda S., Cheng E.H., and Hsieh J.J. Biphasic MLL takes helm at cell cycle control: implications in human mixed lineage leukemia. Cell Cycle 7 (2008) 428-435
54. Gabellini D., Colaluca I.N., Vodermaier H.C., et al. Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression. EMBO J 22 (2003) 3715-3724
55. Seo S., and Kroll K.L. Geminin's double life: chromatin connections that regulate transcription at the transition from proliferation to differentiation. Cell Cycle 5 (2006) 374-379
56. Joo H.Y., Zhai L., Yang C., et al. Regulation of cell cycle progression and gene expression by H2A deubiquitination. Nature 449 (2007) 1068-1072
57. Luo L., Uerlings Y., Happel N., Asli N.S., Knoetgen H., and Kessel M. Regulation of geminin functions by cell cycle-dependent nuclear-cytoplasmic shuttling. Mol Cell Biol 27 (2007) 4737-4744
58. Roche J., Zeng C., Baron A., et al. Hox expression in AML identifies a distinct subset of patients with intermediate cytogenetics. Leukemia 18 (2004) 1059-1063
59. Verhaak R.G., Goudswaard C.S., van Putten W., et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 106 (2005) 3747-3754
60. Wang J., Iwasaki H., Krivtsov A., et al. Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J 24 (2005) 368-381
61. Scholl C., Bansal D., Dohner K., et al. The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Invest 117 (2007) 1037-1048
62. WinMDI Version 2.8. Available at http://facs.scripps.edu/software.html. Accessed April 2, 2008.